As previously reported, UBS upgraded Life360 (LIF) to Buy from Neutral with a price target of $55, up from $52, citing increased confidence in the company’s advertising revenue opportunity. The firm models FY26 revenue 4.5% ahead of consensus, “entirely driven” by its ad revenue estimates, the analyst tells investors.